1032349-96-4

Basic information

• Product Name: 1-(boc-aMino)-1-(4-chlorophenyl)-cyclobutane
• Synonyms: 1-(boc-aMino)-1-(4-chlorophenyl)-cyclobutane;tert-butyl 1-(4-chlorophenyl)cyclobutylcarbamate;Carbamic acid, N-[1-(4-chlorophenyl)cyclobutyl]-, 1,1-dimethylethyl ester
• CAS NO: 1032349-96-4
• Molecular Formula: C₁₅H₂₀ClNO₂
• Molecular Weight: 281.7778
• Mol File: 1032349-96-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 386.3±31.0 °C(Predicted)
• Appearance: /
• Density: 1.16±0.1 g/cm3(Predicted)
• PKA: 11.82±0.20(Predicted)
• CAS DataBase Reference: 1-(boc-aMino)-1-(4-chlorophenyl)-cyclobutane(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(boc-aMino)-1-(4-chlorophenyl)-cyclobutane(1032349-96-4)
• EPA Substance Registry System: 1-(boc-aMino)-1-(4-chlorophenyl)-cyclobutane(1032349-96-4)

Safety Data

• Hazardous Substances Data: 1032349-96-4(Hazardous Substances Data)

Usage

General Description

1-(boc-aMino)-1-(4-chlorophenyl)-cyclobutane is a chemical compound that consists of a cyclobutane ring with a 4-chlorophenyl group and a boc-protected amino group attached to it. The boc group, also known as tert-butoxycarbonyl group, serves as a protecting group for the amino group, providing stability and preventing unwanted reactions. The 4-chlorophenyl group is a substituted phenyl group with a chlorine atom. 1-(boc-aMino)-1-(4-chlorophenyl)-cyclobutane may have potential applications in organic synthesis, medicinal chemistry, or material science. It could also serve as a building block for more complex molecules with specific properties or functions. Additionally, this compound may have biological activities or therapeutic potential that could be explored in future research.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 50921-39-6 1-(4-chlorophenyl)cyclobutane-1-carboxylic acid 

Downstream Products

• 1032528-06-5 {1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclobutyl}-carbamic acid tert.-butyl ester 
• 1032349-97-5 tert-butyl[1-(4-cyanophenyl)cyclobutyl]carbamate 
• 1199555-33-3 N-{1-[4-(1-hydroxy-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl)phenyl]cyclobutyl}-2-(3-pyridinyl)acetamide 
• 1199556-63-2 tert-butyl {1-[4-(1-hydroxy-8-phenyl-[1,2,4]triazole[4,3-a]-1,5-naphthyridin-7-y)phenyl]cyclobutyl}carbamate 
• 1199556-62-1 tert-butyl {1-[4-(6-hydrazino-3-phenyl-1,5-naphthyridin-2-yl)phenyl]cyclobutyl}carbamate 
• 1199556-21-2 7-[4-(1-aminocyclobutyl)phenyl]-N-ethyl-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-1-amine 
• 1199556-61-0 tert-butyl {1-[4-(6-chloro-3-phenyl-1,5-naphthyridin-2-yl)phenyl]cyclobutyl}carbamate 
• 1199555-32-2 7-[4-(1-aminocyclobutyl)-8-phenyl]-[1,2,4]triazole[4,3-a]-1,5-naphthyridin-1-ol 
• 1199556-09-6 7-[4-(1-aminocyclobutyl)phenyl]-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthylidin-1-amine 
• 1199556-10-9 1-[4-(1-methyl-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl)phenyl]cyclobutanamine 
• 1357270-60-0 1-(4-(4-phenylpyrrolo[1,2-a]pyrazin-3-yl)phenyl)cyclobutanamine hydrochloride 
• 1357159-08-0 tert-butyl 1-(4-(4-phenylpyrrolo[1,2-a]pyrazin-3-yl)phenyl)cyclobutylcarbamate 
• 1357159-07-9 tert-butyl 1-(4-(2-(2-formyl-1H-pyrrol-1-yl)-2-phenylacetyl)phenyl)cyclobutylcarbamate 
• 1355998-33-2 2-(4-(1-aminocyclobutyl)phenyl)-3-phenylimidazo[1,2-a]pyridine-7-carboxamide 

Relevant articles and documents

INHIBITORS OF AKT ACTIVITY

The instant invention provides for compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.

Inhibitors of Akt activity

The instant invention provides for substituted naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.